Annual ROA
-59.20%
-0.10%-0.17%
June 30, 2024
Summary
- As of February 26, 2025, INM annual return on assets is -59.20%, with the most recent change of -0.10% (-0.17%) on June 30, 2024.
- During the last 3 years, INM annual ROA has risen by +56.85% (+48.99%).
- INM annual ROA is now -26.77% below its all-time high of -46.70%, reached on June 30, 2018.
Performance
INM ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-66.61%
-11.48%-20.82%
December 31, 2024
Summary
- As of February 26, 2025, INM quarterly return on assets is -66.61%, with the most recent change of -11.48% (-20.82%) on December 31, 2024.
- Over the past year, INM quarterly ROA has stayed the same.
- INM quarterly ROA is now -211.26% below its all-time high of -21.40%, reached on October 31, 2001.
Performance
INM Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
INM ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.2% | 0.0% |
| 3 y3 years | +49.0% | 0.0% |
| 5 y5 years | -6.7% | 0.0% |
INM ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +64.1% | -50.9% | +46.5% |
| 5 y | 5-year | -6.7% | +64.1% | -50.9% | +46.5% |
| alltime | all time | -26.8% | +85.6% | -211.3% | +97.6% |
InMed Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -66.61%(+20.8%) |
| Sep 2024 | - | -55.13%(-6.0%) |
| Jun 2024 | -59.20%(+0.2%) | -58.63%(+31.9%) |
| Mar 2024 | - | -44.44%(+0.7%) |
| Dec 2023 | - | -44.15%(-9.8%) |
| Sep 2023 | - | -48.94%(-9.9%) |
| Jun 2023 | -59.10%(-64.1%) | -54.34%(-47.7%) |
| Mar 2023 | - | -103.88%(-3.0%) |
| Dec 2022 | - | -107.10%(-11.0%) |
| Sep 2022 | - | -120.27%(-3.3%) |
| Jun 2022 | -164.83%(+42.0%) | -124.39%(+32.2%) |
| Mar 2022 | - | -94.11%(-2.4%) |
| Dec 2021 | - | -96.44%(-3.7%) |
| Sep 2021 | - | -100.13%(-5.2%) |
| Jun 2021 | -116.05%(+48.5%) | -105.67%(+15.9%) |
| Mar 2021 | - | -91.21%(+10.7%) |
| Dec 2020 | - | -82.42%(-1.1%) |
| Sep 2020 | - | -83.35%(+2.3%) |
| Jun 2020 | -78.15%(+40.9%) | -81.48%(-2.8%) |
| Mar 2020 | - | -83.79%(+9.1%) |
| Dec 2019 | - | -76.78%(+18.7%) |
| Sep 2019 | - | -64.67%(+17.0%) |
| Jun 2019 | -55.46%(+18.8%) | -55.29%(+8.8%) |
| Mar 2019 | - | -50.83%(+5.6%) |
| Dec 2018 | - | -48.13%(-5.9%) |
| Sep 2018 | - | -51.15%(-10.6%) |
| Jun 2018 | -46.70%(-47.8%) | -57.21%(-22.7%) |
| Mar 2018 | - | -74.03%(-15.5%) |
| Dec 2017 | - | -87.62%(-28.2%) |
| Sep 2017 | - | -122.08%(-0.9%) |
| Jun 2017 | -89.51%(-36.3%) | -123.23%(-8.5%) |
| Mar 2017 | - | -134.70%(+1.9%) |
| Dec 2016 | - | -132.17%(-0.3%) |
| Sep 2016 | - | -132.63%(-10.2%) |
| Jun 2016 | -140.55%(-40.5%) | -147.62%(-32.4%) |
| Mar 2016 | - | -218.51%(-25.2%) |
| Dec 2015 | - | -292.16%(+8.8%) |
| Sep 2015 | - | -268.52%(+5.2%) |
| Jun 2015 | -236.22%(+63.5%) | -255.18%(-14.2%) |
| Mar 2015 | - | -297.50%(+21.4%) |
| Dec 2014 | - | -245.07%(-11.9%) |
| Sep 2014 | - | -278.25%(-22.5%) |
| Jun 2014 | -144.47%(-19.0%) | -359.12%(-87.2%) |
| Mar 2014 | - | -2806.56%(+141.2%) |
| Dec 2013 | - | -1163.49%(+254.3%) |
| Sep 2013 | - | -328.42%(+37.3%) |
| Jun 2013 | -178.38% | -239.23%(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | -289.00%(+38.1%) |
| Dec 2012 | - | -209.22%(+26.5%) |
| Sep 2012 | - | -165.37%(+30.2%) |
| Jun 2012 | -128.41%(-23.9%) | -127.02%(+246.0%) |
| Mar 2012 | - | -36.71%(-67.3%) |
| Dec 2011 | - | -112.25%(-4.9%) |
| Sep 2011 | - | -118.00%(-8.0%) |
| Jun 2011 | -168.64%(-59.0%) | -128.29%(-18.6%) |
| Mar 2011 | - | -157.54%(-27.6%) |
| Dec 2010 | - | -217.61%(-23.4%) |
| Sep 2010 | - | -284.16%(-24.3%) |
| Jun 2010 | -411.00%(+172.7%) | -375.14%(+72.8%) |
| Mar 2010 | - | -217.04%(-22.6%) |
| Dec 2009 | - | -280.43%(+9.1%) |
| Sep 2009 | - | -257.06%(-15.9%) |
| Jun 2009 | -150.70%(+45.8%) | -305.82%(+24.9%) |
| Mar 2009 | - | -244.82%(+24.4%) |
| Dec 2008 | - | -196.76%(-3.8%) |
| Sep 2008 | - | -204.63%(+62.5%) |
| Jun 2008 | -103.37%(-70.9%) | -125.95%(-45.7%) |
| Mar 2008 | - | -231.88%(-22.2%) |
| Dec 2007 | - | -298.05%(-26.4%) |
| Sep 2007 | - | -404.91%(+9.9%) |
| Jun 2007 | -355.31%(+128.5%) | -368.59%(+80.1%) |
| Mar 2007 | - | -204.66%(-2.5%) |
| Dec 2006 | - | -209.97%(+46.8%) |
| Sep 2006 | - | -143.02%(+7.2%) |
| Jun 2006 | -155.53%(-57.2%) | -133.43%(-24.8%) |
| Mar 2006 | - | -177.36%(+37.2%) |
| Dec 2005 | - | -129.23%(-11.3%) |
| Sep 2005 | - | -145.70%(-17.9%) |
| Jun 2005 | -363.08%(+104.2%) | -177.48%(+29.7%) |
| Mar 2005 | - | -136.89%(-19.7%) |
| Dec 2004 | - | -170.39%(-27.3%) |
| Sep 2004 | - | -234.36%(+47.9%) |
| Jul 2004 | -177.79%(+82.6%) | -158.44%(+25.9%) |
| Apr 2004 | - | -125.87%(+2.1%) |
| Jan 2004 | - | -123.33%(+5.6%) |
| Oct 2003 | - | -116.82%(-0.3%) |
| Jul 2003 | -97.39%(+8.4%) | -117.16%(+4.2%) |
| Apr 2003 | - | -112.44%(+0.4%) |
| Jan 2003 | - | -112.02%(+5.6%) |
| Oct 2002 | - | -106.05%(-6.0%) |
| Jul 2002 | -89.87%(-1.6%) | -112.77%(+43.6%) |
| Apr 2002 | - | -78.52%(+65.2%) |
| Jan 2002 | - | -47.52%(+122.1%) |
| Oct 2001 | - | -21.40% |
| Jul 2001 | -91.36% | - |
FAQ
- What is InMed Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual ROA year-on-year change?
- What is InMed Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly ROA year-on-year change?
What is InMed Pharmaceuticals annual return on assets?
The current annual ROA of INM is -59.20%
What is the all time high annual ROA for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual return on assets is -46.70%
What is InMed Pharmaceuticals annual ROA year-on-year change?
Over the past year, INM annual return on assets has changed by -0.10% (-0.17%)
What is InMed Pharmaceuticals quarterly return on assets?
The current quarterly ROA of INM is -66.61%
What is the all time high quarterly ROA for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly return on assets is -21.40%
What is InMed Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, INM quarterly return on assets has changed by 0.00% (0.00%)